GLP-1 drugs like Ozempic, Wegovy, Mounjaro and Zepbound have been revolutionary for weight loss. They’re also sparking big changes in many industries – from food to medicine. Wall Street Journal tech editor Bradley Olson – who himself took a GLP-1 drug – and audio reporter Jessica Mendoza have been documenting impacts of this new class of drugs in a series – “Trillion Dollar Shot” – for our sister podcast The Journal. They answer listener questions on how it’s transforming bodies, fortunes and industries. Luke Vargas hosts.
Further Reading
The Quest for Treatments to Keep Weight Off After Ozempic
Can Ozempic Maker Novo Nordisk Keep Up Its Momentum?
How Drugs Like Ozempic Are Changing What We Think About Weight Loss
Learn more about your ad choices. Visit megaphone.fm/adchoices